Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus by Feher M, Greener M, Munro N

Get full text

Does renal function or heart failure diagnosis affect primary care prescribing for sodium-Glucose co-transporter 2 inhibitors in type 2 diabetes? by Hinton, W, Feher, M, Munro, N, de Lusignan, S

Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis by Feher, M, Hinton, W, Munro, N, De Lusignan, S

Does real world use of liraglutide match its use in the LEADER cardiovascular outcome trial? study protocol by Hinton, W, Feher, M, Munro, N, De Lusignan, S

Sodium-glucose co-transporter 2 (SGLT2) inhibitor: comparing trial data and real-world use by McGovern, A, Feher, M, Munro, N, De Lusignan, S

Variation in the diagnosis and control of hypertension is not explained by conventional variables: Cross-sectional database study in English general practice. by Coyle, R, Feher, M, Jones, S, Hamilton, M, De Lusignan, S

Sodium-glucose co-transporter-2 (SGLT2) inhibitors: comparing trial and real world use (study protocol) by McGovern, A, Feher, M, Munro, N, De Lusignan, S

Sodium-glucose co-transporter-2 inhibitor cardiovascular outcome trials and generalizability to English primary care by Hinton, W, Feher, M, Munro, N, Joy, M, de Lusignan, S

Real-world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice network by Hinton, W, Feher, M, Munro, N, Walker, M, De Lusignan, S

Glycaemic control and folic acid prescription before and during pregnancy in women with diabetes: The Royal College of General Practitioners Research and Surveillance Centre Networ... by Gaudio, M, Feher, M, Dozio, N, Scavini, M, de Lusignan, S

Insulin therapy in type 3c diabetes—more common in chronic rather than acute pancreatitis by Hinton, W, Feher, M, Munro, NM, Coyle, RM, De Lusignan, S

Fenofibrate as a COVID-19 modifying drug: laboratory success versus real-world reality by Feher, M, Joy, M, Munro, N, Hinton, W, Williams, J, de Lusignan, S

Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study by Dambha-Miller, H, Hinton, W, Wilcox, CR, Joy, M, Feher, M, de Lusignan, S

Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol). by De Lusignan, S, Hinton, W, Konstantara, E, Munro, N, Whyte, M, Mount, J, Feher, M

Metformin is associated with reduced risk of venous thromboembolism in Type 2 diabetes: a national primary care database study by Hinton, W, de Lusignan, S, Roberts, L, Arya, R, Feher, M, Munro, N, Whyte, M

Atrial fibrillation dashboard evaluation using the think aloud protocol by de Lusignan, S, Liyanage, H, Sherlock, J, Ferreira, F, Munro, N, Feher, M, Hobbs, R

GLP-1 RA treatment: a benefit-risk analysis from a retrospective cohort study by Konstantara, E, McGovern, AP, Hinton, W, Coyle, R, Feher, M, Munro, N, de Lusignan, S

Improving the management of atrial fibrillation in general practice: Protocol for a mixed method study by de Lusignan, S, Hobbs, FDR, Liyanage, H, Ferreira, F, Tripathy, M, Munro, N, Feher, M, Joy, M

Adherence to general diabetes and foot care processes, with prompt referral, are associated with amputation-free survival in people with type 2 diabetes and foot ulcers: a Scottish... by Meza-Torres, B, Cunningham, SG, Heiss, C, Joy, M, Feher, M, Leese, GP, de Lusignan, S, Carinci, F

Long term follow up of direct oral anticoagulants and warfarin therapy on stroke, with all-cause mortality as a competing risk, in people with atrial fibrillation: sentinel network... by de Lusignan, S, Hobbs, FDR, Liyanage, H, Sherlock, J, Ferreira, F, Tripathy, M, Heiss, C, Feher, M, Joy, MP